首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   313篇
  免费   26篇
  国内免费   1篇
  340篇
  2022年   2篇
  2021年   8篇
  2020年   5篇
  2019年   5篇
  2018年   6篇
  2017年   7篇
  2016年   8篇
  2015年   14篇
  2014年   16篇
  2013年   12篇
  2012年   6篇
  2011年   18篇
  2010年   8篇
  2009年   16篇
  2008年   14篇
  2007年   13篇
  2006年   9篇
  2005年   9篇
  2004年   12篇
  2003年   3篇
  2002年   6篇
  2001年   9篇
  2000年   17篇
  1999年   15篇
  1998年   8篇
  1996年   5篇
  1995年   4篇
  1994年   3篇
  1993年   3篇
  1992年   5篇
  1991年   4篇
  1990年   3篇
  1989年   3篇
  1988年   4篇
  1987年   7篇
  1986年   5篇
  1985年   7篇
  1984年   6篇
  1983年   3篇
  1982年   5篇
  1980年   3篇
  1979年   6篇
  1978年   2篇
  1976年   3篇
  1975年   4篇
  1974年   1篇
  1971年   2篇
  1970年   2篇
  1969年   1篇
  1955年   1篇
排序方式: 共有340条查询结果,搜索用时 15 毫秒
331.
In a prospective study designed to assess the influence of bromocriptine on pituitary tumour size 12 patients with pituitary tumours, eight of whom had suprasellar extensions, were treated for three months with 20 mg of bromocriptine daily after a gradual increase to this dose. The group comprised eight women and four men, five with prolactin-secreting adenomas, four with acromegaly, two with functionless adenomas, and one with Nelson''s syndrome. All five patients with prolactin-secreting adenomas showed a reduction in pituitary tumour size as assessed by computerised tomography and metrizamide cisternography accompanied by a fall in prolactin concentrations and clinical and biochemical improvement in their hypopituitarism. One patient in this group had a visual-field defect before treatment, and this resolved. There was no radiological evidence of reduction in tumour size in the remaining seven patients, though this might refect the fairly short duration of treatment, particularly in view of the ancillary evidence of clinical, biochemical, and visual-field improvement in some of the patients. These results emphasise the potential value of bromocriptine in treating patients with large prolactinomas or recurrences of such tumours after previous chiasmal decompression and conventional external megavoltage irradiation on the pituitary.  相似文献   
332.
333.
The active part or receptor-binding sequence of peptide hormones can usually be defined by a span of 4–8 amino acids. Cyclic penta- and hexapeptides are excellent model systems for performing conformational and structure-function studies on this class of bioactive molecules. A synthetic scheme has been devised comprising solid-phase Fmoc chemistry followed by resin cleavage, cyclization in solution, and, finally, side-chain deprotection. A new resin, DAS, cleaved under weak acid conditions, is an excellent solid-phase synthesis support, and HBTU or PyBOP are the activation reagents of choice, not only during synthesis, but also for the cyclization reaction. Three cyclic peptides were synthesized using this method, one requiring extensive side-chain protection, and this method has general applicability for any cyclic pentapeptide or hexapeptide, giving good yields and high purity.  相似文献   
334.

Background  

Hallucinations occur in 20–40% of PD patients and have been associated with unfavorable clinical outcomes (i.e., nursing home placement, increased mortality). Hallucinations, like other non-motor features of PD, are not well recognized in routine primary/secondary clinical practice. So far, there has been no instrument for uniform characterization of hallucinations in PD. To this end, we developed the University of Miami Parkinson's disease Hallucinations Questionnaire (UM-PDHQ) that allows comprehensive assessment of hallucinations in clinical or research settings.  相似文献   
335.
Developing taste buds in the anterior mandibular floor of perihatching chicks were studied by high voltage electron microscopic autoradiography in order to identify proliferating gemmal cell types. Montaged profiles of 29 taste buds in five cases euthanized between embryonic day 21 and posthatching day 2 were analyzed after a single [3H]thymidine injection administered on embryonic day 16, 17 or 18. Results showed that dark cells comprised 55% of identified (n = 900 cells) and 62% of labeled (n = 568 cells) gemmal cells as compared with light, intermediate, basal or perigemmal bud cells. Dark cells had both a greater (P < 0.05) number of labeled cells and a greater amount of label (grains/nucleus) than the other four bud cell types, irrespective of injection day. The nuclear area (micron 2) of dark cells was not significantly larger (P > 0.05) than that of the other gemmal cell types and therefore cannot account for the greater amount for label in the dark cells. Interestingly, only dark cells showed a positive correlation (P < 0.003) between amount of label and nuclear area. Results suggest that, during the perihatching period of robust cell proliferation, dividing dark cells may give rise primarily, but not exclusively, to dark cell progeny.   相似文献   
336.
337.
Purification and properties of Streptococcus pneumoniae neuraminidase   总被引:7,自引:0,他引:7  
K L Scanlon  W F Diven  R H Glew 《Enzyme》1989,41(3):143-150
Considerable amounts (200 units/ml) of neuraminidase activity were detected in middle ear effusion of children (age 1 month-10 years) and its presence was highly correlated with the presence of Streptococcus pneumoniae. When isolates of this organism are cultured, neuraminidase activity appears in the growth medium during the exponential phase of growth. In order to study the role of this enzyme in the pathology of otitis media we have developed a method for its purification. The enzyme was purified over 5,800-fold by removing the organism and passing the culture broth through a series of affinity and ion-exchange columns. The overall yield was 2 mg enzyme protein and the final specific activity was 1.8 X 10(6) units/mg protein. A molecular weight of 65,000 was estimated by SDS-PAGE and gel filtration chromatography. The Stokes radius of neuraminidase was calculated to be 32 A, its isoelectric point was 7.2, and its pH optimum was 6.0. In terms of specificity, the enzyme catalyzed the hydrolysis of sialic acid linkages in mucin, glycoproteins, and gangliosides: bovine submaxillary mucin supported the highest catalytic efficiency, and alpha-1-antitrypsin the lowest. Neuraminidase acted on at least three linkage classes of substrates, alpha-2,6 and alpha-2,3 linkages of N-acetylneuraminic acid to galactose, and alpha-2,6 linkages to N-acetyl-galactosamine.  相似文献   
338.
339.
Infusion of nonradiolabelled dehydroepiandrosterone sulphate (DHA-S) has been used to investigate the possible formation of oestrone sulphate via a sulphated conjugate of androstenedione. The metabolic clearance rate (MCR) of DHA-S also was measured and the mean value (25 1/24h) was similar to values reported using isotopic techniques. Although conversion of DHA-S to 5-androstenediol, a steroid with oestrogenic properties, was detected during infusion of DHA-S, there were no significant increases in plasma levels of conjugated androstenedione or oestrone sulphate. The MCR's oestrone sulphate measured using infusion of nonradiolabelled steroid in two menopausal women were 99 1/24h and 121 1/24h. For one woman, the production rate of oestrone sulphate, calculated from the conversion of oestrone and oestradiol to oestrone sulphate (151 nmol/day) was similar to the measured production rate of oestrone sulphate (144 nmol/day). It is concluded that in menopausal women, oestrone sulphate is derived from conversion of oestrone and oestradiol with no formation occurring via conjugated androstenedione.  相似文献   
340.
A male pseudohermaphrodite white-tailed deer (Odocoileus virginianus) is described. The animal shot in Aiken County, South Carolina on November 4, 1971, was 1.5 years old and had the external appearance of an antlered doe. The 6 point antlers were in velvet, a vulva was present, and the testes were located in the body cavity. Other male reproductive organs present were epididymides, vasa deferentia and ampullae. Female reproductive organs present were cervix, vagina and clitoris.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号